<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-22400" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Granuloma Annulare</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Schmieder</surname>
            <given-names>Shawn J.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Harper</surname>
            <given-names>Chelsea D.</given-names>
          </name>
          <aff>Campbell University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Schmieder</surname>
            <given-names>George J.</given-names>
          </name>
          <aff>Orange Park</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Shawn Schmieder declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Chelsea Harper declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>George Schmieder declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>21</day>
          <month>6</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-22400.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Granuloma annulare is a cutaneous granulomatous disease that is not caused by an infection. It is the most common non-infectious granulomatous disease. The disease is benign and often self-limited. Granuloma annulare usually presents as erythematous plaques or papules arranged in an annular configuration on the upper extremities. In addition to the more common presentation, termed localized granuloma annulare, other clinical variants of granuloma annulare include generalized, perforating, patch, and subcutaneous. Despite being a benign disease, it can be associated with more serious conditions such as HIV or malignancy. This activity explains when granuloma annulare should be considered in the differential diagnosis, articulates how to evaluate for this condition properly, and highlights the role of the interprofessional team in caring for patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the pathophysiology of granuloma annulare.</p></list-item><list-item><p>Summarize the presentation of granuloma annulare.</p></list-item><list-item><p>Outline the co-morbidities associated with granuloma annulare.</p></list-item><list-item><p>Explain when granuloma annulare should be considered in the differential diagnosis, articulate how to properly evaluate for this condition, and highlight the role of the interprofessional team in caring for patients with this condition.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=22400&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=22400">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-22400.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Granuloma annulare (GA) is a cutaneous granulomatous disease of unknown etiology. It is the most common non-infectious granulomatous disease. The disease is benign and often self-limited. Granuloma annulare usually presents as erythematous plaques or papules arranged in an annular configuration on the upper extremities. In addition to the more common presentation, termed localized granuloma annulare, other clinical variants of granuloma annulare include generalized, perforating, patch, and subcutaneous.<xref ref-type="bibr" rid="article-22400.r1">[1]</xref><xref ref-type="bibr" rid="article-22400.r2">[2]</xref><xref ref-type="bibr" rid="article-22400.r3">[3]</xref> Despite being a&#x000a0;benign disease, it can be associated with more serious conditions such as HIV or malignancy.<xref ref-type="bibr" rid="article-22400.r4">[4]</xref></p>
      </sec>
      <sec id="article-22400.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The etiology and pathogenesis of granuloma annulare are largely unknown. However, the disease has been associated with diabetes mellitus, thyroid disease, mild trauma, hyperlipidemia, infections (Ebstein-Barr Virus, human immunodeficiency virus, varicella-zoster virus, tuberculosis), vaccines, malignancy, and certain drugs (TNF-alpha inhibitors). Despite the classic association with diabetes, the evidence is lacking to support a true association with diabetes. Experts believe that a clinician should screen for malignancy in a patient with granuloma annulare under the following circumstances: older age, atypical or widespread presentation, and recalcitrant disease. However, more evidence is needed to establish a true correlation between granuloma annulare and malignancy. Studies&#x000a0;suggest that HIV patients are more likely to have generalized granuloma annulare. There are also reports of highly atypical presentations of granuloma annulare in patients with HIV. Antiretroviral drugs have been found to both improve and exacerbate HIV. Patients with new-onset granuloma annulare who have risk factors for HIV should be screened for HIV. Also, patients with the generalized type or perforating type of granuloma annulare should be screened for HIV.<xref ref-type="bibr" rid="article-22400.r5">[5]</xref><xref ref-type="bibr" rid="article-22400.r6">[6]</xref></p>
      </sec>
      <sec id="article-22400.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The prevalence of granuloma annulare is estimated to be 0.1% to 0.4%, and the estimated incidence is 0.1% to 0.4%. Women are affected more commonly than men, and the disease can affect persons of any age. More than two-thirds of patients are 30 years of age or younger.&#x000a0;</p>
      </sec>
      <sec id="article-22400.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The etiology and pathogenesis of this disease are unknown.&#x000a0;Some believe that granuloma annulare is caused by a delayed-type hypersensitivity reaction, more specifically a Th1 reaction involving IFN-gamma stimulating macrophages to release matrix metalloproteinases. This ultimately results in connective tissue degradation. Some studies provide support for this theory. For example, helper T cells have been found in samples of granuloma annulare lesions. Another study showed that a significant number of T cells in these lesions were CD3+ and had interferon-gamma receptors. It was also found that macrophages found in the lesions were differentiated to effector cells that expressed matrix metalloproteinases and tumor necrosis factor-alfa.</p>
        <p>Impaired neutrophil chemotaxis has been found in patients with granuloma annulare. The authors of this study postulated that macrophages take over an inflammatory site because of the impaired neutrophil response, which leads to the granulomatous inflammation seen in granuloma annulare as opposed to a suppurative neutrophil type inflammation.</p>
      </sec>
      <sec id="article-22400.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Histologically granuloma annulare is characterized by focal collagen degeneration, inflammation with interstitial histiocytes, and mucin deposition. Four different histopathological patterns are observed; interstitial (57.9%), palisaded granulomatous (26.3%), sarcoidal granulomatous, and mixed. The palisading pattern consists of a rim of histiocytes and lymphocytes that surround an area of necrobiotic collagen. The interstitial pattern consists of histiocytes scattered among bundles of collagen and blood vessels in the dermis. A patient may have more than one of the histopathologic subtypes.</p>
      </sec>
      <sec id="article-22400.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Granuloma annulare is often located on the lateral and dorsal hands and feet in a ring-like or circinate con&#x000ad;figuration. There is usually no pruritus or other symptoms associated with the lesions. The localized variant is the most common subtype of granuloma annulare and represents approximately 75% of the reported cases of granuloma annulare.</p>
        <p>In addition to the localized variant, other clinical variants of granuloma annulare include generalized, perforating, patch, and subcutaneous. Generalized granuloma annulare presents with numerous flesh-colored papules in an annular configuration on the trunk and extremities. Unlike the classic presentation, these lesions are often pruritic. Up to 15% of granuloma annulare cases are of the generalized type. This subtype rarely resolves on its own and has a poor response to therapy.</p>
        <p>Subcutaneous granuloma annulare presents with large nodules on the extremities. These nodules are sometimes called pseudorheumatoid nodules. Subcutaneous granuloma annulare&#x000a0;is&#x000a0;seen almost exclusively in children; the age range for developing the disease is about 1 to 14 years of age.</p>
        <p>The patch variant of granuloma annulare presents with erythematous patches that may involve large areas of skin. There is some overlap between this subtype and reactive granulomatous eruptions; differentiating between the two is sometimes difficult.&#x000a0;Perforating granuloma annulare presents with umbilicated papules. The lesions may be confined to the extremities or involve the trunk and the extremities.&#x000a0;It is estimated that approximately half of the patients with the localized form of granuloma annulare will experience spontaneous remission within a 2-year period. A patient may have more than one of the subtypes of granuloma annulare.</p>
      </sec>
      <sec id="article-22400.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Granuloma annulare is diagnosed&#x000a0;by correlating clinical presentation (see above) with the histologic features found on biopsy (see above).</p>
      </sec>
      <sec id="article-22400.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Although the lesions of granuloma annulare usually regress, they tend to recur. For this reason, and for cosmetic reasons, treatment&#x000a0;sometimes&#x000a0;is indicated. Physicians try many therapies, but there is little research-based evidence to support them. Further, in one study conducted with 67 granuloma annulare patients, researchers did not find a significant difference between the duration of lesions between untreated and treated patients.<xref ref-type="bibr" rid="article-22400.r7">[7]</xref><xref ref-type="bibr" rid="article-22400.r5">[5]</xref><xref ref-type="bibr" rid="article-22400.r8">[8]</xref><xref ref-type="bibr" rid="article-22400.r9">[9]</xref></p>
        <p>Despite the lack of evidence, experts agree that intralesional steroid injection is first-line therapy for lesions of granuloma annulare. There are reports of improvement after certain types of trauma to the lesions such as biopsy, pricking, incision, and cryotherapy. Phototherapy has shown promising results in some studies. There are reports of success with both excimer laser and pulsed dye laser. Hydroxychloroquine has shown success in a few small studies and reports. Although more evidence is needed to prove efficacy, some researchers believe that hydroxychloroquine should be first-line therapy for generalized granuloma annulare. Tumor necrosis factor-alpha inhibitors have shown efficacy in treating generalized and recalcitrant granuloma annulare. However, as mentioned above, there are reports of TNF-alpha inhibitors triggering or exacerbating the disease, so more research is needed to weigh the risks and the benefits of using TNF-alpha inhibitors to treat this disease. Physicians have also tried surgical excision, but lesions tend to recur.</p>
        <p>In addition to the therapy mentioned above, vitamin E, isotretinoin, tetracyclines, intralesional interferons, topical imiquimod, niacinamide, oral calcitriol, dapsone, hydroxyurea, topical tacrolimus, clofazimine, and rifampin have been tried and reported to be effective in small studies.</p>
      </sec>
      <sec id="article-22400.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Actinic granuloma annulare</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Dermoid cyst</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Erythema nodosum</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Erythema annulare centrifugum</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Elastosis perforans serpiginosa</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Foreign body granuloma</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Insect bite</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Lichen planus</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Necrobiosis lipoidica diabeticorum</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Perforating granuloma annulare</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Perforating collagenosis</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Rheumatoid nodule</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Subcutaneous granuloma annulare</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Sarcoidosis</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-22400.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Granuloma annulare is a benign, often self-limiting condition.&#x000a0;Lesions can disappear spontaneously without sequelae, typically within several months to years. There is no satisfactory&#x000a0;treatment for GA, but since the lesions are&#x000a0;usually&#x000a0;asymptomatic, watchful waiting is often acceptable.</p>
        <p>For most patients, the condition disappears&#x000a0;within a few years. It tends to&#x000a0;be more persistent when it&#x000a0;spreads to&#x000a0;other areas (generalized form) than&#x000a0;when it is only in one location (localized form).</p>
      </sec>
      <sec id="article-22400.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Granuloma annulare is a benign, often self-limiting condition.&#x000a0;</p>
      </sec>
      <sec id="article-22400.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>There is not much that patients&#x000a0;can do to influence the course of granuloma annulare.&#x000a0;No evidence&#x000a0;exists showing diet&#x000a0;to influence the condition. Patients can use skin camouflage to conceal affected areas.</p>
      </sec>
      <sec id="article-22400.s14" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>More research is needed to better determine the epidemiology, disease associations, pathophysiology, and treatment of this disease.</p>
      </sec>
      <sec id="article-22400.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Patients with granuloma annulare may present to their primary care provider, internist, or dermatologist. The key thing to know is that this skin lesion is benign and can spontaneously regress. Most cases do not require any treatment. However, patients do seek treatment for cosmesis. Unfortunately, despite the availability of dozens of treatments, none works with any reliability or consistency; recurrences are common with all treatments.<xref ref-type="bibr" rid="article-22400.r10">[10]</xref><xref ref-type="bibr" rid="article-22400.r11">[11]</xref></p>
      </sec>
      <sec id="article-22400.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=22400&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=22400">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/skin-problems-and-treatments/granuloma-annulare/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=22400">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/22400/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=22400">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-22400.s17">
        <fig id="article-22400.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Granuloma Annulare <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://dermnetnz.org/images">DermNet New Zealand</ext-link></p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="granuloma__annulare" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-22400.s18">
        <fig id="article-22400.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Granuloma Annulare Child Contributed by Dr. Shyam Verma, MBBS, DVD, FRCP, FAAD, Vadodara, India</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="granuloma__annulare__child__SV1" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-22400.s19">
        <fig id="article-22400.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Granuloma Annulare adult Contributed by Dr. Shyam Verma, MBBS, DVD, FRCP, FAAD, Vadodara, India</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Granuloma__annulare__SV1" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-22400.s20">
        <fig id="article-22400.image.f4" position="float" orientation="portrait">
          <caption>
            <p>Multiple Granuloma Annulare Contributed by Dr. Shyam Verma, MBBS, DVD, FRCP, FAAD, Vadodara, India</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Multiple__Granuloma__annulare__SV1" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-22400.s21">
        <fig id="article-22400.image.f5" position="float" orientation="portrait">
          <caption>
            <p>Granuloma annulare, H/E 4x. Multiple areas of central collagenolysis surrounded by an eosinophilic collagenous collarette and peripheric histiocytes. Contributed by Fabiola Farci, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="granuloma__ann01" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-22400.s22">
        <title>References</title>
        <ref id="article-22400.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rubin</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Rosenbach</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Granuloma annulare: a retrospective series of 133 patients.</article-title>
            <source>Cutis</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>103</volume>
            <issue>2</issue>
            <fpage>102</fpage>
            <page-range>102-106</page-range>
            <pub-id pub-id-type="pmid">30893387</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22400.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ronen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rothschild</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Suster</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>The interstitial variant of granuloma annulare: Clinicopathologic study of 69 cases with a comparison with conventional granuloma annulare.</article-title>
            <source>J Cutan Pathol</source>
            <year>2019</year>
            <month>Jul</month>
            <volume>46</volume>
            <issue>7</issue>
            <fpage>471</fpage>
            <page-range>471-478</page-range>
            <pub-id pub-id-type="pmid">30883851</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22400.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gabald&#x000f3;n</surname>
                <given-names>VH</given-names>
              </name>
              <name>
                <surname>Haro-Gonz&#x000e1;lez-Vico</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Lack of an association between generalized granuloma annulare and malignancy: A case-control study.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>80</volume>
            <issue>6</issue>
            <fpage>1799</fpage>
            <page-range>1799-1800</page-range>
            <pub-id pub-id-type="pmid">30826288</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22400.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Imadojemu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rosenbach</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Advances in Inflammatory Granulomatous Skin Diseases.</article-title>
            <source>Dermatol Clin</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>37</volume>
            <issue>1</issue>
            <fpage>49</fpage>
            <page-range>49-64</page-range>
            <pub-id pub-id-type="pmid">30466688</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22400.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Errichetti</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Stinco</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Dermatoscopy of Granulomatous Disorders.</article-title>
            <source>Dermatol Clin</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>36</volume>
            <issue>4</issue>
            <fpage>369</fpage>
            <page-range>369-375</page-range>
            <pub-id pub-id-type="pmid">30201146</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22400.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Terziroli Beretta-Piccoli</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Mainetti</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Peeters</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Laffitte</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Cutaneous Granulomatosis: a Comprehensive Review.</article-title>
            <source>Clin Rev Allergy Immunol</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>54</volume>
            <issue>1</issue>
            <fpage>131</fpage>
            <page-range>131-146</page-range>
            <pub-id pub-id-type="pmid">29352388</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22400.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Truong</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Worswick</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>The role of biologics in the treatment of chronic granuloma annulare.</article-title>
            <source>Int J Dermatol</source>
            <year>2019</year>
            <month>May</month>
            <volume>58</volume>
            <issue>5</issue>
            <fpage>622</fpage>
            <page-range>622-626</page-range>
            <pub-id pub-id-type="pmid">30618205</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22400.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Khachemoune</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Granuloma Annulare: A Focused Review of Therapeutic Options.</article-title>
            <source>Am J Clin Dermatol</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>19</volume>
            <issue>3</issue>
            <fpage>333</fpage>
            <page-range>333-344</page-range>
            <pub-id pub-id-type="pmid">29230666</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22400.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Asai</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>What is new in the histogenesis of granulomatous skin diseases?</article-title>
            <source>J Dermatol</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>44</volume>
            <issue>3</issue>
            <fpage>297</fpage>
            <page-range>297-303</page-range>
            <pub-id pub-id-type="pmid">28256762</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22400.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Min</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Lebwohl</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Treatment of recalcitrant granuloma annulare (GA) with adalimumab: A single-center, observational study.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2016</year>
            <month>Jan</month>
            <volume>74</volume>
            <issue>1</issue>
            <fpage>127</fpage>
            <page-range>127-33</page-range>
            <pub-id pub-id-type="pmid">26552891</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22400.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Passeron</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Fusade</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Vabres</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bousquet-Rouaud</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Collet-Vilette</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Dahan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Toubel</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Treatment of granuloma annulare with the 595-nm pulsed dye laser, a multicentre retrospective study with long-term follow-up.</article-title>
            <source>J Eur Acad Dermatol Venereol</source>
            <year>2013</year>
            <month>Jun</month>
            <volume>27</volume>
            <issue>6</issue>
            <fpage>785</fpage>
            <page-range>785-8</page-range>
            <pub-id pub-id-type="pmid">22188443</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
